117 related articles for article (PubMed ID: 10573320)
1. Vitamin E in the treatment of tardive dyskinesia.
Boomershine KH; Shelton PS; Boomershine JE
Ann Pharmacother; 1999 Nov; 33(11):1195-202. PubMed ID: 10573320
[TBL] [Abstract][Full Text] [Related]
2. Vitamin E supplementation in Alzheimer's disease, Parkinson's disease, tardive dyskinesia, and cataract: Part 2.
Pham DQ; Plakogiannis R
Ann Pharmacother; 2005 Dec; 39(12):2065-72. PubMed ID: 16288072
[TBL] [Abstract][Full Text] [Related]
3. The effect of vitamin E treatment on tardive dyskinesia and blood superoxide dismutase: a double-blind placebo-controlled trial.
Zhang XY; Zhou DF; Cao LY; Xu CQ; Chen DC; Wu GY
J Clin Psychopharmacol; 2004 Feb; 24(1):83-6. PubMed ID: 14709952
[TBL] [Abstract][Full Text] [Related]
4. Treatment of tardive dyskinesia with vitamin E.
Egan MF; Hyde TM; Albers GW; Elkashef A; Alexander RC; Reeve A; Blum A; Saenz RE; Wyatt RJ
Am J Psychiatry; 1992 Jun; 149(6):773-7. PubMed ID: 1350428
[TBL] [Abstract][Full Text] [Related]
5. Oxidative mechanisms and tardive dyskinesia.
Lohr JB; Kuczenski R; Niculescu AB
CNS Drugs; 2003; 17(1):47-62. PubMed ID: 12467492
[TBL] [Abstract][Full Text] [Related]
6. Vitamin E in tardive dyskinesia: time course of effect after placebo substitution.
Adler LA; Peselow E; Duncan E; Rosenthal M; Angrist B
Psychopharmacol Bull; 1993; 29(3):371-4. PubMed ID: 8121964
[TBL] [Abstract][Full Text] [Related]
7. Melatonin for the treatment of tardive dyskinesia.
Nelson LA; McGuire JM; Hausafus SN
Ann Pharmacother; 2003; 37(7-8):1128-31. PubMed ID: 12841828
[TBL] [Abstract][Full Text] [Related]
8. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.
Lohr JB; Caligiuri MP
J Clin Psychiatry; 1996 Apr; 57(4):167-73. PubMed ID: 8601552
[TBL] [Abstract][Full Text] [Related]
9. Vitamin E (alpha-tocopherol) in the treatment of tardive dyskinesia: a statistical meta-analysis.
Barak Y; Swartz M; Shamir E; Stein D; Weizman A
Ann Clin Psychiatry; 1998 Sep; 10(3):101-5. PubMed ID: 9781472
[TBL] [Abstract][Full Text] [Related]
10. Tardive dyskinesia: possible involvement of free radicals and treatment with vitamin E.
Elkashef AM; Wyatt RJ
Schizophr Bull; 1999; 25(4):731-40. PubMed ID: 10667743
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment effects of vitamin E for tardive dyskinesia.
Adler LA; Edson R; Lavori P; Peselow E; Duncan E; Rosenthal M; Rotrosen J
Biol Psychiatry; 1998 Jun; 43(12):868-72. PubMed ID: 9627740
[TBL] [Abstract][Full Text] [Related]
12. Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanisms.
Lohr JB; Cadet JL; Lohr MA; Larson L; Wasli E; Wade L; Hylton R; Vidoni C; Jeste DV; Wyatt RJ
Schizophr Bull; 1988; 14(2):291-6. PubMed ID: 2904696
[TBL] [Abstract][Full Text] [Related]
13. Vitamin E treatment of tardive dyskinesia.
Adler LA; Peselow E; Rotrosen J; Duncan E; Lee M; Rosenthal M; Angrist B
Am J Psychiatry; 1993 Sep; 150(9):1405-7. PubMed ID: 8102511
[TBL] [Abstract][Full Text] [Related]
14. Severe tardive dyskinesia in affective disorders: treatment with vitamin E and C.
Michael N; Sourgens H; Arolt V; Erfurth A
Neuropsychobiology; 2002; 46 Suppl 1():28-30. PubMed ID: 12571430
[TBL] [Abstract][Full Text] [Related]
15. Tardive dyskinesia, lipid peroxidation, and sustained amelioration with vitamin E treatment.
Peet M; Laugharne J; Rangarajan N; Reynolds GP
Int Clin Psychopharmacol; 1993; 8(3):151-3. PubMed ID: 8263312
[TBL] [Abstract][Full Text] [Related]
16. Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia.
Margolese HC; Chouinard G; Kolivakis TT; Beauclair L; Miller R; Annable L
Can J Psychiatry; 2005 Oct; 50(11):703-14. PubMed ID: 16363464
[TBL] [Abstract][Full Text] [Related]
17. Vitamin E in the treatment of tardive dyskinesia.
Akhtar S; Jajor TR; Kumar S
J Postgrad Med; 1993; 39(3):124-6. PubMed ID: 7914238
[TBL] [Abstract][Full Text] [Related]
18. The Nithsdale Schizophrenia Surveys. XIV: Plasma lipid peroxide and serum vitamin E levels in patients with and without tardive dyskinesia, and in normal subjects.
McCreadie RG; MacDonald E; Wiles D; Campbell G; Paterson JR
Br J Psychiatry; 1995 Nov; 167(5):610-7. PubMed ID: 8564316
[TBL] [Abstract][Full Text] [Related]
19. The current status of tardive dyskinesia.
Sachdev PS
Aust N Z J Psychiatry; 2000 Jun; 34(3):355-69. PubMed ID: 10881961
[TBL] [Abstract][Full Text] [Related]
20. Are calcium-channel blockers effective in the treatment of tardive dyskinesia?
Cates M; Lusk K; Wells BG
Ann Pharmacother; 1993 Feb; 27(2):191-6. PubMed ID: 7679936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
